Last reviewed · How we verify
FLUENZ
At a glance
| Generic name | FLUENZ |
|---|---|
| Also known as | Influenza vaccine, LAIV, FLUMIST |
| Sponsor | Imperial College London |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE (NA)
- Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children (PHASE4)
- Immune Response To Intranasal Influenza Vaccination (NA)
- FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV (NA)
- Nasal and Systemic Immune Responses to Nasal Influenza Vaccine (NA)
- Effect of Treatment With the Ablative Fractional Carbodioxide Laser in Vulvar Lichen Sclerosis (NA)
- Safety of Nasal Influenza Immunisation in Egg Allergic Children
- Efficacy & Safety of Nasal Influenza Immunisation in Children (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |